Paramètres
En savoir plus sur le livre
In this thesis, the process-technical prerequisites were achieved to provide new cow antibody-based therapeutic options for bacterial infections as substitutes for non-specific antibiotics. Microfiltration was investigated for the fractionation of antibodies from milk and a new scalable chromatography process for the isolation of IgG was developed. Specific polyclonal antibodies were induced by immunization of cows in milk, the products obtained were characterized and their efficacy demonstrated for the treatment of Clostridium difficile infection in an animal model.
Nous avons un total de du titre From food to medicine: process development and use of functionalized polyclonal antibodies from cow's milk for the treatment of infections caused by multi-resistant bacteria (2019).
Achat du livre
From food to medicine: process development and use of functionalized polyclonal antibodies from cow's milk for the treatment of infections caused by multi-resistant bacteria, Hans-Jürgen Heidebrecht
- Langue
- Année de publication
- 2019,
- État du livre
- Bon
- Prix
- 3,99 €
Modes de paiement
Personne n'a encore évalué .
- Titre
- From food to medicine: process development and use of functionalized polyclonal antibodies from cow's milk for the treatment of infections caused by multi-resistant bacteria
- Langue
- Anglais
- Auteurs
- Hans-Jürgen Heidebrecht
- Éditeur
- Dr. Hut
- Publié
- 2019
- ISBN10
- 3843942684
- ISBN13
- 9783843942683
- Séries
- Mots clés
- Nonfiction, Santé & Médecine, Médecine
- Description
- In this thesis, the process-technical prerequisites were achieved to provide new cow antibody-based therapeutic options for bacterial infections as substitutes for non-specific antibiotics. Microfiltration was investigated for the fractionation of antibodies from milk and a new scalable chromatography process for the isolation of IgG was developed. Specific polyclonal antibodies were induced by immunization of cows in milk, the products obtained were characterized and their efficacy demonstrated for the treatment of Clostridium difficile infection in an animal model.